Physician profile
Alice Ye
NPI 1508326497
$4,220.73
in general payments reported to CMS, 2019-2025
11 companies · $3,704 in 2025
The $3,704 reported for 2025 was more than what 96% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $245 · 2024: $271 · 2025: $3,704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,799 · Grant: $1,515 · Travel and Lodging: $907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,799.20 |
| Grant | $1,515.00 |
| Travel and Lodging | $906.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,963.59 | 2023-2025 | Infinity, Proclaim, Eterna |
| Medtronic, INC. | $369.89 | 2023-2025 | Intellis Adaptivestim, Inceptiv |
| Saluda Medical Americas, INC. | $229.05 | 2025 | Evoke |
| Averitas Pharma INC. | $166.66 | 2025 | Qutenza |
| Boston Scientific Corporation | $142.83 | 2025 | General - Pain Management |
| Abbvie INC. | $85.87 | 2025 | |
| Spr Therapeutics, INC | $80.45 | 2025 | Sprint Pns System |
| Tersera Therapeutics LLC | $71.80 | 2025 | Prialt |
| Stryker Corporation | $60.26 | 2023-2025 | Augment Injectable, Spinejack |
| Biotronik Nro, INC. | $25.49 | 2025 | Prospera |
| Vertex Pharmaceuticals Incorporated | $24.84 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alice Ye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.